Aelis Farma Sa Stock Current Valuation
| AELIS Stock | 2.20 0.20 8.33% |
Valuation analysis of Aelis Farma SA helps investors to measure Aelis Farma's intrinsic value by examining its available valuation indicators, including the cash flow records, the balance sheet account changes and income statement patterns.
Overvalued
Today
Please note that Aelis Farma's price fluctuation is risky at this time. Calculation of the real value of Aelis Farma SA is based on 3 months time horizon. Increasing Aelis Farma's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Aelis Farma's intrinsic value may or may not be the same as its current market price of 2.20, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 2.2 | Real 2.3 | Hype 2.4 |
The intrinsic value of Aelis Farma's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence Aelis Farma's stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of Aelis Farma SA helps investors to forecast how Aelis stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Aelis Farma more accurately as focusing exclusively on Aelis Farma's fundamentals will not take into account other important factors: Aelis Farma SA Company Current Valuation Analysis
Aelis Farma's Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.
Current Aelis Farma Current Valuation | 102.61 M |
Most of Aelis Farma's fundamental indicators, such as Current Valuation, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Aelis Farma SA is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Enterprise Value can be a useful tool to compare companies with different capital structures. Long term liability and current cash or cash equivalents can have a huge impact on market valuation of a given company.
| Competition |
In accordance with the recently published financial statements, Aelis Farma SA has a Current Valuation of 102.61 M. This is 99.29% lower than that of the Healthcare sector and 97.79% lower than that of the Biotechnology industry. The current valuation for all France stocks is 99.38% higher than that of the company.
Aelis Current Valuation Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Aelis Farma's direct or indirect competition against its Current Valuation to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Aelis Farma could also be used in its relative valuation, which is a method of valuing Aelis Farma by comparing valuation metrics of similar companies.Aelis Farma is currently under evaluation in current valuation category among its peers.
Aelis Fundamentals
| Return On Equity | -1.0 | |||
| Return On Asset | -0.11 | |||
| Profit Margin | (2.04) % | |||
| Operating Margin | (1.01) % | |||
| Current Valuation | 102.61 M | |||
| Shares Outstanding | 12.5 M | |||
| Shares Owned By Institutions | 0.20 % | |||
| Price To Book | 5.85 X | |||
| Price To Sales | 21.46 X | |||
| Revenue | 9.07 M | |||
| Gross Profit | 10.76 M | |||
| EBITDA | (6.7 M) | |||
| Net Income | 574 K | |||
| Cash And Equivalents | 24.71 M | |||
| Total Debt | 3.26 M | |||
| Book Value Per Share | 1.91 X | |||
| Cash Flow From Operations | 18.97 M | |||
| Earnings Per Share | 0.32 X | |||
| Target Price | 21.5 | |||
| Number Of Employees | 22 | |||
| Market Capitalization | 177.77 M | |||
| Total Asset | 28.31 M | |||
| Z Score | 32.4 | |||
| Net Asset | 28.31 M |
About Aelis Farma Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Aelis Farma SA's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Aelis Farma using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Aelis Farma SA based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for Aelis Stock Analysis
When running Aelis Farma's price analysis, check to measure Aelis Farma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Aelis Farma is operating at the current time. Most of Aelis Farma's value examination focuses on studying past and present price action to predict the probability of Aelis Farma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Aelis Farma's price. Additionally, you may evaluate how the addition of Aelis Farma to your portfolios can decrease your overall portfolio volatility.